Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
Open Access
- 21 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (5) , ziae011
Abstract
G protein-coupled receptors (GPCRs) mediate a wide spectrum of physiological functions, including the development, remodeling, and repair of the skeleton. Fibrous dysplasia (FD) of the bone is characterized by fibrotic, expansile bone lesions caused by activating mutations in GNAS. There are no effective therapies for FD. We previously showed that ColI(2.3)+/Rs1+ mice, in which Gs-GPCR signaling was hyper-activated in osteoblastic cell lineages using an engineered receptor strategy, developed a fibrotic bone phenotype with trabecularization that could be reversed by normalizing Gs-GPCR signaling, suggesting that targeting the Gs-GPCR or components of the downstream signaling pathway could serve as a promising therapeutic strategy for FD. The Wnt signaling pathway has been implicated in the pathogenesis of FD-like bone, but the specific Wnts and which cells produce them remain largely unknown. Single-cell RNA sequencing on long-bone stromal cells of 9-wk-old male ColI(2.3)+/Rs1+ mice and littermate controls showed that fibroblastic stromal cells in ColI(2.3)+/Rs1+ mice were expanded. Multiple Wnt ligands were up- or downregulated in different cellular populations, including in non-osteoblastic cells. Treatment with the porcupine inhibitor LGK974, which blocks Wnt signaling broadly, induced partial resorption of the trabecular bone in the femurs of ColI(2.3)+/Rs1+ mice, but no significant changes in the craniofacial skeleton. Bone fibrosis remained evident after treatment. Notably, LGK974 caused significant bone loss in control mice. These results provide new insights into the role of Wnt and Gs-signaling in fibrosis and bone formation in a mouse model of Gs-GPCR pathway overactivation. Fibrous dysplasia (FD) of the bone is a debilitating disease caused by a somatic, mosaic genetic mutation in GNAS, leading to Gs-GPCR signaling overactivation in affected cells. We previously showed that ColI(2.3)+/Rs1+ mice, in which Gs-GPCR signaling is activated in osteoblastic lineage cells using an engineered receptor strategy, develop a fibrotic bone phenotype with trabecular bone overgrowth. In this study, we performed scRNA-seq on bone harvested from ColI(2.3)+/Rs1+ mice and littermate controls and show that Wnt signaling is upregulated in ColI(2.3)+/Rs1+ mice. We subsequently treated ColI(2.3)+/Rs1+ mice with LGK974, a porcupine inhibitor that broadly blocks Wnt signaling, and observed a partial decrease in trabecular bone volume but no change in the dense fibrotic infiltration in the long bones of ColI(2.3)+/Rs1+ mice. Furthermore, LGK974 was associated with toxicity in control bone that limits its clinical utility. These findings lay the foundation for future studies to understand how individual Wnt ligands may contribute to FD pathogenesis.Keywords
Funding Information
- University of California Department of Medicine Robert L. Kroc Chair of Rheumatic and Connective Tissue Diseases III
- Kaohsiung Chang Gung Memorial Hospital
- Chang Gung University College of Medicine Doctoral Training Fellowship
- National Institutes of Health (NIDCR R01 DE022032, NIDCR R21 DE027138, NIAMS AR056299)
- NIDCR K08 Career Development Award (DE028946)
- NIH Loan Repayment Award (1 L30 DE029063-01)
- University of Pennsylvania Million Dollar Bike Ride (MDBR-19-111-FD/MAS)
- UCSF Core Center for Musculoskeletal Biology and Medicine (NIH P30AR075055)
This publication has 85 references indexed in Scilit:
- The Promise and Perils of Wnt Signaling Through β-CateninScience, 2002
- Classifying G-protein coupled receptors with support vector machinesBioinformatics, 2002
- Craniofacial fibrous dysplasia of the fronto-orbital region: A case series and literature reviewJournal of Oral and Maxillofacial Surgery, 2001
- Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular boneJournal of Clinical Investigation, 2001
- Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled ReceptorsEndocrine Reviews, 2000
- prx-1 functions cooperatively with another paired-related homeobox gene,prx-2, to maintain cell fates within the craniofacial mesenchymeDevelopment, 1999
- The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs? gene: site-specific patterns and recurrent histological hallmarksThe Journal of Pathology, 1999
- Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbsDevelopment, 1998
- Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.Journal of Clinical Investigation, 1998
- Activating Mutations of the Stimulatory G Protein in the McCune–Albright SyndromeNew England Journal of Medicine, 1991